Boston Scientific Scimed, Inc.

Ams Research Corporation

American Medical Systems, Inc.

Astora Women's Health, LLC

Bayer Healthcare LLC

Robert C Grant

Edouard A Koullick

James Ryan Mujwid

Karl Alan Jagger

Balkrishna S Jadhav

Sidney F Hauschild

Jessica Lynn Roll

Mark Gregory Polyak

Thomas Q Dinh

Stephen L Bolea

Johann J Neisz

William Stephen Tremulis

John R Frigstad

Jeffrey A Lechner-Riehle

Embodiments of elongate pelvic implants and methods for treating pelvic conditions, such as incontinence, are provided. The implants can include a tissue support portion, one or more extension portions and one or more anchors. The implant is constructed as a unitary sling implant. The implant can be constructed or formed in a generally elongate shape to provide a lattice support structure of repeated cells.

Patterned sling implant and method

Described are methods, devices, and systems related to implants for the treatment of a female pelvic condition. The implants include absorbable and non-absorbable materials and can be introduced into the pelvic area transvaginally. Meshes of the invention provide benefits relating to improved tissue integration into the mesh, reduced infection likelihood, improved patient comfort following implantation, or combinations of thereof.

Implants with absorbable and non-absorbable features for the treatment of female pelvic conditions

Described are methods, devices, and systems related to pelvic implants, including implants that include absorbable and non-absorbable materials.

Bioabsorbable mesh for surgical implants

An occlusion device is described and depicted for occluding a body lumen. The device can comprise an occluding body member and one or more protruding portions or members disposed on the body member such that the protruding portion is provided with spacing, or surface area, to allow for tissue in-growth. The device can also comprise an expandable plug. The expandable plug may be twisted or otherwise formed into a shape, e.g., helical, in its initial deployment configuration, and untwist upon deployment.

Body lumen occlusion device and method

A foreign body retrieval device is disclosed. The device moves between an open position for receiving the foreign body and a closed position for capturing the foreign body. A novel method for retrieving a foreign body such as a stent is also disclosed.

Foreign body retrieval device and method

A design and method of manufacture are disclosed for a female continence augmentor device used to alleviate urinary incontinence. The female continence augmentor includes a mount formed of a resilient material, an intralumenal part carried on the mount and a resilient portion carried on the intralumenal part of device. The mount adheres to the female body about the urethral exit to support the female augmentor into position to prevent inadvertent urine loss. The intralumenal part of the device extends from the mount into the urethral lumen at least to the mid-urethra. In particular, the resilient portion of the intralumenal part extends into the urethra and is adapted to at least urge the dorsal urethral wall in the dorsal direction to stretch and/or reshape the mid-urethral lumen to have a more arcuate shape. Thus, the mid-urethral lumen in cross-section would preferably exhibit a crescent shape of smaller radius. As such, the female continence augmentor enables a patient to void voluntarily with normal muscle control and without requiring conscious action to operate the device. Following voiding, the continence augmentation function of the device resumes automatically thereby increasing urethral resistance to opening and preventing inadvertent urine loss.

Urinary continence device and methods for urinary control

A female continence augmentor stops involuntary urine loss due to transient increases in bladder pressure but allows urine flow when automatically opened by transmitted bladder pressure during voluntary voiding. The augmentor improves coaptation and increases midurethral resistance to opening with a resilient mount releasably adhered adhesively to the body in position to prevent inadvertent urine loss. An intralumenal part on the mount has a resilient portion extending into the urethra for urging the dorsal midurethral wall in a dorsal direction for stretching and/or reshaping the midurethral lumen to an arc. The portion has a member located to engage the midurethral wall. A coaptation improver on the member engages with the adjacent midurethra. The improver carries biocompatible hydrophilic material adapted to coact with mucus and mucosa within the urethra. A coated biocompatible hydrophilic membrane can be the member with opposed generally rectangular major surfaces and is circumscribed by an edge. The hydrophilic membrane is bowed along the edge transverse between sides thereof for bearing against the inside of the midurethral walls. The membrane has a mesh of flexible polymer and an arc shape between the sides so the opposed major surfaces are concave and convex. Two struts can extend from the sides to the portion. A method of making the augmentor has the steps of forming the mount of resilient material. The resilient material adheres to the body to support the augmentor in position to prevent inadvertent urine loss through the midurethral lumen. The part on the mount extends into the urethra. Connecting the part to the mount and locating the member on the portion for placement relative to the mount intralumenally is a step. The method step of forming includes molding the mount of a polymer. The step of locating the member uses at least one or two struts. The method has the step of adding an adhesive to the mount and increasing coaptation of the portion with a material. A method of using the augmentor has the steps of inserting the part into the urethra so that the member is within the midurethral lumen and placing the mount adjacent to the urethral exit to retain the member therein. Applying resistance inside the urethra with the member by the portion is a step of using. Urging the dorsal midurethral wall in a dorsal direction and engaging the urethral wall, especially the midurethral wall to remove laxity therein are steps of using.

Growing community of inventors

Minneapolis, MN, United States of America

Robert C Grant